PKM and colorectal carcinoma: It has been reported that the lncRNA FEZF1‐AS1, which is upregulated in CRC patients, enhances CRC cell proliferation and metastasis via both glycolysis and STAT3 signalling by binding to PKM2 and increasing its stability [88].